We are live on ! Find out more
VVM

Versant Venture Management Portfolio holdings

AUM $163M
1-Year Est. Return 240.43%
This Fund
S&P 500
This Quarter Est. Return
+58.68%
1 Year Est. Return
+240.43%
3 Year Est. Return
+409.28%
5 Year Est. Return
+142.09%
10 Year Est. Return
+4,071.98%
AUM
$105M
AUM Growth
–
Cap. Flow
+$85.5M
Cap. Flow %
81.8%
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$42.8M
2
FPRX
Five Prime Therapeutics, Inc.
FPRX
+$18.8M
3
AKAO
Achaogen Inc
AKAO
+$13M
4
CBAY
Cymabay Therapeutics
CBAY
+$8.43M
5
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
+$2.46M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 97.67%
2 Miscellaneous 2.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLVS
1
DELISTED
Clovis Oncology, Inc.
CLVS
$45.6M 43.63%
+814,833
New +$42.8M
FPRX
2
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$29.5M 28.2%
+1,092,152
New +$18.8M
AKAO
3
DELISTED
Achaogen Inc
AKAO
$16.7M 15.99%
+1,281,152
New +$13M
CBAY
4
DELISTED
Cymabay Therapeutics
CBAY
$10.3M 9.86%
+1,048,601
New +$8.43M
KYTH
5
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$2.44M 2.33%
+70,376
New +$2.46M

Similar funds

TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
GF
Gimbal Financial Carmel, Indiana $163M AUM
ACM
Arrington Capital Management Miami, Florida $163M AUM
KFS
Krane Financial Solutions Calabasas, California $162M AUM
VB
Value Base Tel Aviv, Israel $162M AUM 2.31% 1-Year Est. Return
RWA
Reicon Wealth Advisors Atlanta, Georgia $162M AUM
CCM
Candelo Capital Management New York $162M AUM 112.87% 1-Year Est. Return
GCM
Generation Capital Management Pittsford, New York $163M AUM 42.22% 1-Year Est. Return

Versant Venture Management's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Versant Venture Management, which disclosed 5 positions worth $105M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Clovis Oncology, Inc.: 814,833 shares worth $45.6M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, followed by Miscellaneous.

  • Versant Venture Management's largest Q4 2014 buy was Clovis Oncology, Inc.: 814,833 shares worth $45.6M.
  • Versant Venture Management's ten largest holdings make up 100% of its $105M portfolio in Q4 2014.
  • Versant Venture Management disclosed 5 positions in Q4 2014, its first 13F filing on record.

Based on Versant Venture Management's 13F filing for Q4 2014, filed 2 Apr 2015.